Agree with what you about Sonic’’s characteristics as an investment @Gindaldan, but am more positive than you are about the recent acquisition of Pathology Watch.
I can’t claim to understand the applicable technology, but it sounds like a desirable step towards digital pathology and AI, and Sonic’s assets should complement it nicely (apparently). You’re right, it’s not yet profitable, but it’s only costing 1.5% of market cap and the financial benefits are medium term. I’m actually pleased management is taking a long term view of things.
I doubt it impacted the share price much, as it’s a relatively small bolt on, although I respect that you might have been watching that more closely than I did and drew your conclusion accordingly. Anyway, hopefully in 5 years time we might look back on the Pathology Watch purchase and say it was a good move, albeit initially profit less.
- Forums
- ASX - By Stock
- SHL
- Next Update Pending
Next Update Pending, page-61
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$26.98 |
Change
-0.210(0.77%) |
Mkt cap ! $12.96B |
Open | High | Low | Value | Volume |
$26.85 | $27.05 | $26.85 | $29.92M | 1.109M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10039 | $26.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$27.04 | 824 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 605 | 28.320 |
1 | 56 | 27.780 |
1 | 52 | 27.500 |
1 | 185 | 27.050 |
1 | 40 | 27.000 |
Price($) | Vol. | No. |
---|---|---|
25.640 | 691 | 1 |
26.150 | 26 | 1 |
26.190 | 3 | 1 |
26.480 | 33 | 1 |
26.800 | 266 | 2 |
Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
Featured News
SHL (ASX) Chart |